GlassScriptPhysician profile
Daniel Sequoyah Tuell
NPI 1639601115
$2,176.35
in general payments reported to CMS, 2019-2025
13 companies · $1,390 in 2025
The $1,390 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $41.69 · 2024: $745 · 2025: $1,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,077 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,077.36 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $950.40 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $371.29 | 2023-2025 | Dupixent |
| Inspire Medical Systems, INC. | $233.16 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $204.18 | 2024-2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $98.99 | 2024 | |
| Cochlear Americas | $84.39 | 2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Aerin Medical INC. | $65.11 | 2025 | |
| Integra Lifesciences Corporation | $44.67 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Alk-Abello, INC | $43.24 | 2024-2025 | Pre-Pen, Alternaria Tenuis, Timothy, Standardized |
| Smith+Nephew, INC. | $28.44 | 2024 | Tula |
| Phathom Pharmaceuticals, INC. | $20.54 | 2024 | Voquezna |
| Stryker Corporation | $16.76 | 2024 | Medline Industries, INC. |
| Hikma Pharmaceuticals USA | $15.18 | 2024 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Tuell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.